Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis.
Tali ShaltielDaniel SolomonEric R PletcherBenjamin J GolasDeepa R MaggeUmut SarpelDaniel M LabowNoah A CohenPublished in: Surgical endoscopy (2022)
This preliminary study demonstrates that laparoscopic CRS/HIPEC is feasible and safe for curative treatment in selected patients with low tumor volume. Minimally invasive CRS/HIPEC is associated with fewer postoperative complications and shorter length of stay. There was no difference in long-term oncological outcomes between the groups.
Keyphrases
- minimally invasive
- robot assisted
- rectal cancer
- patients undergoing
- prostate cancer
- locally advanced
- cardiac surgery
- type diabetes
- coronary artery bypass
- squamous cell carcinoma
- radical prostatectomy
- radiation therapy
- skeletal muscle
- replacement therapy
- surgical site infection
- percutaneous coronary intervention
- combination therapy